Los Angeles Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-15,175
| Closed | -$170K | – | 1463 |
|
|
2017
Q3 | $170K | Hold |
15,175
| – | – | ﹤0.01% | 1262 |
|
|
2017
Q2 | $167K | Sell |
15,175
-1,600
| -10% | -$17.6K | ﹤0.01% | 1163 |
|
|
2017
Q1 | $164K | Buy |
16,775
+1,607
| +11% | +$15.7K | ﹤0.01% | 1110 |
|
|
2016
Q4 | $164K | Hold |
15,168
| – | – | ﹤0.01% | 1124 |
|
|
2016
Q3 | $155K | Buy |
+15,168
| New | +$155K | ﹤0.01% | 1184 |
|
|
2016
Q2 | – | Sell |
-10,548
| Closed | -$116K | – | 1315 |
|
|
2016
Q1 | $116K | Sell |
10,548
-1,225
| -10% | -$13.5K | ﹤0.01% | 1095 |
|
|
2015
Q4 | $108K | Hold |
11,773
| – | – | ﹤0.01% | 1105 |
|
|
2015
Q3 | $82K | Hold |
11,773
| – | – | ﹤0.01% | 1140 |
|
|
2015
Q2 | $116K | Hold |
11,773
| – | – | ﹤0.01% | 1183 |
|
|
2015
Q1 | $104K | Hold |
11,773
| – | – | ﹤0.01% | 1190 |
|
|
2014
Q4 | $103K | Buy |
11,773
+625
| +6% | +$5.47K | ﹤0.01% | 1093 |
|
|
2014
Q3 | $77K | Sell |
11,148
-940
| -8% | -$6.49K | ﹤0.01% | 1048 |
|
|
2014
Q2 | $64K | Sell |
12,088
-24,215
| -67% | -$128K | ﹤0.01% | 1182 |
|
|
2014
Q1 | $165K | Sell |
36,303
-160
| -0.4% | -$727 | ﹤0.01% | 1208 |
|
|
2013
Q4 | $184K | Sell |
36,463
-2,110
| -5% | -$10.6K | ﹤0.01% | 1221 |
|
|
2013
Q3 | $196K | Buy |
+38,573
| New | +$196K | ﹤0.01% | 1239 |
|